Invesco Health Care Invstor holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invesco Health Care Fund Investor Class GTHIX
- NAV / 1-Day Return $42.25 / +0.60 %
- Fund Size $1.3B
- Adjusted Expense Ratio 1.070%
- Net Expense Ratio 1.060%
- Fee Level: Distribution Average
- Share Class Type No Load
- Morningstar Category Health
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 59%
Morningstar’s Analysis GTHIX
Will GTHIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 10.37 | 129M | Healthcare |
Johnson & Johnson | 6.82 | 85M | Healthcare |
UnitedHealth Group Inc | 5.28 | 66M | Healthcare |
Merck & Co Inc | 5.06 | 63M | Healthcare |
AbbVie Inc | 4.00 | 50M | Healthcare |
argenx SE ADR | 3.51 | 44M | Healthcare |
Gilead Sciences Inc | 3.31 | 41M | Healthcare |
Vertex Pharmaceuticals Inc | 2.40 | 30M | Healthcare |
Welltower Inc | 2.29 | 28M | Real Estate |
CVS Health Corp | 2.20 | 27M | Healthcare |